BMY vs PPL · P/E 17, rev $24.46B vs P/E 22, rev $9.04B
Bristol-Myers Squibb Company (BMY) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported PPL revenue for 2025-12-31 was $9.04B. Net income was $1.18B. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the BMY and PPL stock pages for the full models.
Not investment advice.